Related Experiment Video

Updated: Dec 25, 2025

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
08:54

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

14.7K

Local Treatment of 'Oligometastases': Wishful Thinking is Not Supported by Available Evidence - Authors' Reply

P H Patel1, A-M Shiarli1, A C Tree1

  • 1Radiotherapy Department, The Royal Marsden Hospital, Sutton, UK.

Clinical Oncology (Royal College of Radiologists (Great Britain))
|March 24, 2020
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.8K
Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma
09:52

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Published on: January 25, 2015

13.8K

Related Experiment Videos

Last Updated: Dec 25, 2025

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
08:54

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

14.7K
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.8K
Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma
09:52

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Published on: January 25, 2015

13.8K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Cancer Therapies02:49

Cancer Therapies

9.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.7K

Articles linked to this work by shared authors, journal, and citation graph.

How to focal boost in prostate cancer radiotherapy: ESTRO clinical practice consensus recommendations.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026

The impact of body mass index on Esophagectomy: perioperative and oncological outcomes.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2026

Is rectal preparation necessary in contemporary image-guided prostate radiotherapy?

Clinical and translational radiation oncology·2026

Does Overall Treatment Time Impact Toxicity and Clinical Outcomes After Magnetic Resonance Imaging-Guided Stereotactic Body Radiotherapy to the Prostate? An evaluation of the Multi-OutcoMe EvaluatioN of radiation Therapy Using the MR-Linac Repository.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026

ESMO-ESTRO consensus statements on the safety of combining radiotherapy with EGFR, ALK, or BRAF/MEK inhibitors.

ESMO open·2026

Real-world 5-year outcomes with durvalumab after chemoradiotherapy in unresectable stage III NSCLC.

ESMO open·2026

Real-world Experience with Sotorasib in KRAS G12C-Mutated Advanced Non-small Cell Lung Cancer: Clinical Outcomes and Tolerability in the UK.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026

Acute Myocardial Infarction in Head and Neck Cancer Patients and Survivors: A Population-Based Cohort Study of Patient, Disease, and Treatment Factors.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026

Patient-reported Outcomes after Standard and Dose-escalated Prostate Stereotactic Body Radiotherapy.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026

A Multicentre Retrospective Cohort Study of Hypofractionated Radiotherapy in Head and Neck Cancer.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026

UK Photon Radiotherapy Practice for Oligodendroglioma -Data From the Analysis of Proton vs Photon Radiotherapy in Oligodendroglioma and Assessment of Cognitive Health Trial (ISRCTN:1339049) Radiotherapy Quality Assurance (RTQA) Programme.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026

Whole-pelvic Versus Prostate-only Radiotherapy in Clinically Node-negative High-Risk Localised Prostate Cancer: A Systematic Review and Meta-analysis with Reconstructed Individual-patient Data.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026

New Progress in Pathological Classification and Treatment of Intracranial Chordoma.

Journal of visualized experiments : JoVE·2026

One patient with synchronous multiple primary colon cancers which is easy to miss: a case report.

Frontiers in surgery·2026

Performance of a multi-cancer early detection test in the randomized controlled NHS-Galleri trial.

Nature medicine·2026

Verification of human nucleotide sequence reagents and cell line identities in original circRNA articles published in high impact factor journals.

RNA (New York, N.Y.)·2026

Toward Standardized Reporting in Non-Traumatic Osteonecrosis of the Femoral Head: Recommendations for Clinical Study Design and Reporting.

The Journal of arthroplasty·2026

Erratum.

Cells, tissues, organs·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us